ArriVent BioPharma Stock Forward View - Accumulation Distribution
| AVBP Stock | 21.95 -0.23 -1.04% |
ArriVent BioPharma's Accumulation Distribution reference data reflects the model's output when applied to available daily price observations. This page summarizes the model output and key accuracy metrics for reference. The projected value and error metrics are calculated from available daily price observations.
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume The Accumulation Distribution reference values for ArriVent BioPharma are derived from publicly available price data and should be used for informational purposes only. Accumulation Distribution Analysis Today
ArriVent BioPharma Common has current Accumulation Distribution of 17240.98. The accumulation distribution (A/D) indicator shows the degree to which ArriVent BioPharma is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of ArriVent BioPharma Common to determine if accumulation or reduction is taking place in the market. This value is adjusted by ArriVent BioPharma trading volume to give more weight to distributions with higher volume over lower volume.| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 21547.18 | 17240.98 |
| Volatility | Backtest | Information Ratio |
ArriVent BioPharma Trading Date Momentum
| On March 24 2026 ArriVent BioPharma Common was traded for 21.95 at the closing time. The top price for the day was 22.08 and the lowest listed price was 21.09 . The trading volume for the day was 384.5 K. The trading history from March 24, 2026 did not affect price variability. The overall trading delta against the current closing price is -0.18% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare ArriVent BioPharma to competition |
Other Forecasting Options for ArriVent BioPharma
Relative Strength Index values for ArriVent measure the speed and magnitude of recent price changes. Recognizing these clusters in ArriVent BioPharma's returns helps calibrate position size and stop-loss levels. Candlestick pattern analysis of ArriVent Stock daily data can reveal short-term reversal or continuation signals.ArriVent BioPharma Related Equities
Investors studying ArriVent BioPharma often look at related stocks within the Health Care space to gauge pricing and results. Revenue and margin checks across this group help investors set expectations for ArriVent BioPharma's results. Falling behind peers on key ratios may signal headwinds or execution issues worth looking into. The peer review below gives a clear framework for judging ArriVent BioPharma's standing among rivals.
| Risk & Return | Correlation |
ArriVent BioPharma Market Strength Events
Market strength indicators provide a structured view of how ArriVent BioPharma stock is positioned relative to trends. These indicators are valuable tools for identifying when to enter or exit positions in ArriVent BioPharma Common. These signals help validate or refine position timing for ArriVent BioPharma.
ArriVent BioPharma Risk Indicators
The analysis of ArriVent BioPharma's risk metrics is one of the most important steps in projecting its future price. This process quantifies the risk associated with ArriVent BioPharma's and helps determine how to manage it. A structured analysis of ArriVent BioPharma's risk indicators is one of the most reliable ways to improve forecast accuracy.
| Mean Deviation | 2.71 | |||
| Semi Deviation | 3.12 | |||
| Standard Deviation | 3.65 | |||
| Variance | 13.31 | |||
| Downside Variance | 9.97 | |||
| Semi Variance | 9.71 | |||
| Expected Short fall | -3.32 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for ArriVent BioPharma
Story coverage around ArriVent BioPharma Common often expands when market conditions, narrative momentum, or risk-adjusted performance make the security more visible to investors. This is most useful when investors want to understand why a security is suddenly drawing more public discussion.
Contributor Headline
Latest Perspective From Macroaxis
ArriVent BioPharma Short Properties
Reviewing short-oriented indicators for ArriVent BioPharma Common is useful because long and short participants often create very different signals for timing and volatility. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 38.5 M | |
| Cash And Short Term Investments | 312.8 M |
Additional Tools for ArriVent Stock Analysis
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |